Footwear brand Dr Martens said trading since the start of its current financial year has been in line with expectations, ahead of its annual general meeting.
Direct-to-consumer (DTC) sales in the Americas, particularly full-price retail, continued to perform well.
Growth in the Asia-Pacific region, especially in South Korea, also supported overall results. These helped offset softer trading in Europe, where the UK market remains challenging.
Autumn/Winter order books were described as healthy, with year-on-year increases in EMEA and stable volumes in the Americas, which now include a broader product mix.
The company confirmed that guidance for FY26 remains unchanged and said it remains focused on implementing its new “consumer-first” Levers for Growth strategy, which aims to expand market reach, increase purchase occasions, and simplify operations.
Further updates will follow in November.
image - Dr Martens
京公网安备 11010202009378号
